• Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
  • Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
  • Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
  • Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
  • Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
  • Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib

Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Powder
Purity: >99%
Samples:
US$ 25/g 1 g(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Datails
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Pazopanib
Product Name
Pazopanib
Name
Pazopanib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
635702-64-6
Mf
C21h23n7o2s.Clh
MW
473.987
Boiling Point
>290c
Einecs
619-728-0
Transport Package
Negotiable
Specification
Negotiable
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
500kg/Month

Product Description

Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib Hcl Intermediate Pazopanib
Product Description

 

Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate PazopanibUnii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
Product Datails

 

Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
Product name Pazopanib
Cas number 635702-64-6
Apperance White Powder
Boiling Point 290°
MF C21H23N7O2S.ClH
MW 473.987
Pazopanib is researched and developed by a GlaxoSmithKline ,it is a novel oral vascular generation inhibitor which may interfere stubborn tumor survival and new blood vessels generation growth needed .Targeting vascular endothelial receptor (VEGFR),it works by inhibiting angiogenesis of tumor blood supply.      it is suitable for advanced renal cell carcinoma ( a discovery of cancer cells in the renal tubules), soft tissue sarcoma (STS), epithelial ovarian cancer and non-small cell lung cancer (NSCLC) treatment.
Application&Function

 

Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate PazopanibPazopanib Hydrochloride is the hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity.         Pazopanib selectively inhibits vascular endothelial receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived  receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.
Pazopanib Indications:
1.    FDA-approved for patients with advanced kidney cancer.
2.    FDA-approved for patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy.
Specification

 

Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib
Unii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate PazopanibUnii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate PazopanibUnii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate PazopanibUnii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate PazopanibUnii-33y9anm545 Pazopanib Hydrochloride Pazopanib HCl Intermediate Pazopanib

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP